BICO BICO Group AB (publ)

1.567USD15.92 SEK · STO-2.33%Mkt Cap: 110.59M USDP/E: —

BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through two segments: Life Science Solutions and Lab Automation. The …

Key Statistics

Company
Market Cap110.59M USD
Enterprise Value124.61M USD
Revenue (TTM)155.76M USD
Gross Profit76.80M USD
Net Income (TTM)-107.18M USD
Revenue/Share2.21 USD
Last Price1.567 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees512
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0013647385
Valuation
P/E (Trailing)—
P/E (Forward)-30.04
PEG—
EV/EBITDA-1.82
EV/Revenue0.80
P/S0.71
P/B0.83
EPS (TTM)-0.63 USD
EPS (Forward)-0.05 USD
52W Range
1.27424% of range2.500
52W High2.500 USD
52W Low1.274 USD
Profitability
Gross Margin52.12%
Oper. Margin-4.63%
EBITDA Margin-43.84%
Profit Margin-72.73%
ROE-62.27%
ROA-29.46%
ROIC-13.38%
ROCE-11.59%
Growth
Revenue Growth20.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF6.73M USD
CapEx (TTM)2.46M USD
FCF Margin-33.14%
FCF Yield-46.67%
Net Debt14.02M USD
Net Debt/EBITDA-0.21
Net Debt/FCF—
Balance Sheet
Debt/Equity0.74
Current Ratio2.46
Quick Ratio1.89
Book Value/Sh1.88 USD
Cash/Share0.77 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split4:1
Split DateJan 10, 2020
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.101 USD
Upside (mean)+97.9%
Target Range1.969 USD – 4.232 USD
1.969+97.9% to mean4.232
# Analysts2
Ownership
Shares Out.69.07M
Float49.63M
Insiders28.60%
Institutions23.27%
Technical
SMA 502.185 (-28.3%)
SMA 2001.840 (-14.8%)
Beta2.49
S&P 52W Chg12.00%
Avg Vol (30d)546.75K
Avg Vol (10d)1.27M
Technical Indicators
RSI (14)26.0
MACD-1.9476
MACD Signal-1.0659
MACD Hist.-0.8817
BB Upper2.876 USD
BB Middle2.105 USD
BB Lower1.334 USD
BB Width73.23%
ATR (14)0.1416 USD
Vol Ratio (20d)0.73x

About BICO Group (STO: BICO)

›

BICO Group (STO: BICO) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 512 employees.

The shares were at 15.92 SEK on 19 November 2026, down 21.3% over 52 weeks. Its 52-week range is 12.94 SEK to 25.40 SEK: the price is 37.3% below the high and 23.0% above the low.

Its market capitalisation is 1.12B SEK.

BICO Group reports return on equity of -62.3%, an operating margin of -4.6% and revenue up 20.2% year over year.

Its debt exceeds its cash by 142.40M SEK, a debt-to-equity ratio of 0.74. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 2 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 31.50 SEK is 97.9% above the current price. The next earnings report is expected on 17 February 2027.